Cargando…

Inhibitory effects of selected isoquinoline alkaloids against main protease (M(pro)) of SARS-CoV-2, in silico study

The COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a global threat. Despite the production of various vaccines and different treatments, finding natural compounds to control COVID-19 is still a challenging task. Isoquinoline alkaloids are naturall...

Descripción completa

Detalles Bibliográficos
Autores principales: Sadeghi, Morteza, Miroliaei, Mehran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918422/
https://www.ncbi.nlm.nih.gov/pubmed/35310017
http://dx.doi.org/10.1007/s40203-022-00122-4
_version_ 1784668724175831040
author Sadeghi, Morteza
Miroliaei, Mehran
author_facet Sadeghi, Morteza
Miroliaei, Mehran
author_sort Sadeghi, Morteza
collection PubMed
description The COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a global threat. Despite the production of various vaccines and different treatments, finding natural compounds to control COVID-19 is still a challenging task. Isoquinoline alkaloids are naturally occurring compounds known to have some potential antiviral activity. In this study, ten abundant isoquinoline alkaloids with antiviral activity were selected to analyze the preventive effect on COVID-19. A scrutinized evaluation based on Lipinski’s rule showed that one out of ten compounds was toxic. Based on molecular docking analysis using Autodock software one of the best molecules with maximum negative binding energy was selected for further analysis. The Gromacs simulation analysis revealed that Coptisine has more action against active site M(pro) of COVID-19. Overall, to make a rational design of various preventive analogues that inhibit the COVID-19, associated in vitro and in vivo analyses are needed to confirm this claim.
format Online
Article
Text
id pubmed-8918422
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-89184222022-03-14 Inhibitory effects of selected isoquinoline alkaloids against main protease (M(pro)) of SARS-CoV-2, in silico study Sadeghi, Morteza Miroliaei, Mehran In Silico Pharmacol Original Research The COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a global threat. Despite the production of various vaccines and different treatments, finding natural compounds to control COVID-19 is still a challenging task. Isoquinoline alkaloids are naturally occurring compounds known to have some potential antiviral activity. In this study, ten abundant isoquinoline alkaloids with antiviral activity were selected to analyze the preventive effect on COVID-19. A scrutinized evaluation based on Lipinski’s rule showed that one out of ten compounds was toxic. Based on molecular docking analysis using Autodock software one of the best molecules with maximum negative binding energy was selected for further analysis. The Gromacs simulation analysis revealed that Coptisine has more action against active site M(pro) of COVID-19. Overall, to make a rational design of various preventive analogues that inhibit the COVID-19, associated in vitro and in vivo analyses are needed to confirm this claim. Springer Berlin Heidelberg 2022-03-14 /pmc/articles/PMC8918422/ /pubmed/35310017 http://dx.doi.org/10.1007/s40203-022-00122-4 Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022
spellingShingle Original Research
Sadeghi, Morteza
Miroliaei, Mehran
Inhibitory effects of selected isoquinoline alkaloids against main protease (M(pro)) of SARS-CoV-2, in silico study
title Inhibitory effects of selected isoquinoline alkaloids against main protease (M(pro)) of SARS-CoV-2, in silico study
title_full Inhibitory effects of selected isoquinoline alkaloids against main protease (M(pro)) of SARS-CoV-2, in silico study
title_fullStr Inhibitory effects of selected isoquinoline alkaloids against main protease (M(pro)) of SARS-CoV-2, in silico study
title_full_unstemmed Inhibitory effects of selected isoquinoline alkaloids against main protease (M(pro)) of SARS-CoV-2, in silico study
title_short Inhibitory effects of selected isoquinoline alkaloids against main protease (M(pro)) of SARS-CoV-2, in silico study
title_sort inhibitory effects of selected isoquinoline alkaloids against main protease (m(pro)) of sars-cov-2, in silico study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918422/
https://www.ncbi.nlm.nih.gov/pubmed/35310017
http://dx.doi.org/10.1007/s40203-022-00122-4
work_keys_str_mv AT sadeghimorteza inhibitoryeffectsofselectedisoquinolinealkaloidsagainstmainproteasemproofsarscov2insilicostudy
AT miroliaeimehran inhibitoryeffectsofselectedisoquinolinealkaloidsagainstmainproteasemproofsarscov2insilicostudy